Contract HHSN272201800006I; southern research institute; medicinal chemistry and problem solving synthesis for antivirals; OA task 75N93021F00001; MIS task TOIA21B23OBRRTR3; base award; can 8051543;…

Ended Awarded Last action

Contract number
75N93021F00001
Awardee
Awarding agency
Obligated
$1,909,506

Award facts

Opportunity
  • B23 Solicitation number
Contract value 87% obligated
  • $1,909,506.00 Current, with exercised options
  • $2,206,021.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Birmingham, AL 35205, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Exercise an Option P00006 $346,221
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 · Non-clinical services for development of interventional agents for infectious diseases $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $1,563,285

About this award

The National Institute of Allergy and Infectious Diseases awarded Southern Research Institute a $1.56 million delivery order under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery/indefinite quantity (IDIQ) contract. The award funds medicinal chemistry and problem-solving synthesis for antiviral compounds, as well as non-clinical services supporting the development of therapeutic agents for infectious diseases. Work will be performed at Southern Research's Birmingham, Alabama facility under a cost-plus-fixed-fee pricing structure, with a completion date of January 31, 2026 and a ceiling value of $2.21 million. No set-aside designation was applied to this delivery order.

Southern Research Institute is a nonprofit research organization with extensive capabilities in biomedical research, drug discovery, and preclinical testing for federal agencies. The Institute holds multiple large IDIQ contracts with NIAID totaling hundreds of millions of dollars for infectious disease modeling and therapeutic development services. This delivery order represents targeted work within the broader NIAID relationship and aligns with the agency's mission to support the development of medical countermeasures and interventional agents for infectious diseases, particularly in antiviral compound development.

Description

Contract HHSN272201800006I; southern research institute; medicinal chemistry and problem solving synthesis for antivirals; OA task 75N93021F00001; MIS task TOIA21B23OBRRTR3; base award; can 8051543; total $1,563,285.00

Quick answers

Who was awarded contract 75N93021F00001?

75N93021F00001 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 27, 2021.

How much is contract 75N93021F00001 worth?

The government has obligated $1,909,506 on 75N93021F00001. Its potential value, with all options, is $2,206,021.

Is contract 75N93021F00001 an order under another contract?

Yes. 75N93021F00001 is a delivery order under 75N93018D00006, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.

Was contract 75N93021F00001 competed?

The extent of competition for 75N93021F00001 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award